Intratympanic Sustained-Exposure Dexamethasone Thermosensitive Gel for Symptoms of Ménière's Disease: Randomized Phase 2b Safety and Efficacy Trial

OBJECTIVE: To evaluate safety and efficacy of a single intratympanic injection of OTO-104, sustained-exposure dexamethasone, in patients with unilateral Ménière's disease. STUDY DESIGN: Randomized, double-blind, placebo-controlled, Phase 2b study over 5 months. SETTING: Fifty-two academic and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambert, Paul R., Carey, John, Mikulec, Anthony A., LeBel, Carl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Medical Neurotology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414596/
https://www.ncbi.nlm.nih.gov/pubmed/27749754
http://dx.doi.org/10.1097/MAO.0000000000001227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414596/
https://www.ncbi.nlm.nih.gov/pubmed/27749754
http://dx.doi.org/10.1097/MAO.0000000000001227

Ejemplares similares